Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorTimmerman, John
dc.contributor.authorHerbaux, Charles
dc.contributor.authorRibrag, Vincent
dc.contributor.authorZelenetz, Andrew D.
dc.contributor.authorHouot, Roch
dc.contributor.authorNeelapu, Sattva S.
dc.contributor.authorCarpio Segura, Cecilia Carmen
dc.date.accessioned2021-11-10T11:24:55Z
dc.date.available2021-11-10T11:24:55Z
dc.date.issued2020-05
dc.identifier.citationTimmerman J, Herbaux C, Ribrag V, Zelenetz AD, Houot R, Neelapu SS, et al. Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma. Am J Hematol. 2020 May;95:510–20.
dc.identifier.issn1096-8652
dc.identifier.urihttps://hdl.handle.net/11351/6523
dc.descriptionLimfoma de cèl·lules B; Urelumab
dc.description.sponsorshipResearch funding from Bristol-Myers Squibb, Kite/Gilead, Merck, and Spectrum Pharmaceuticals.
dc.language.isoeng
dc.publisherWiley
dc.relation.ispartofseriesAmerican Journal of Hematology;95
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectCèl·lules B - Tumors - Tractament
dc.subjectMedicaments antineoplàstics - Ús terapèutic
dc.subject.meshLymphoma, Large B-Cell, Diffuse
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols
dc.subject.mesh/therapeutic use
dc.titleUrelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1002/ajh.25757
dc.subject.decslinfoma de células B grandes difuso
dc.subject.decsprotocolos de quimioterapia antineoplásica combinada
dc.subject.decs/uso terapéutico
dc.relation.publishversionhttps://doi.org/10.1002/ajh.25757
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Timmerman J] UCLA Medical Center, Los Angeles, California. [Herbaux C] Centre Hospitalier Régional Universitaire de Lille, Lille, France. [Ribrag V] Institut Gustave Roussy, Villejuif, France. [Zelenetz AD] Memorial Sloan Kettering Cancer Center, New York, New York. [Houot R] CHU Rennes, Service Hématologie Clinique, Rennes, France. INSERM, Unité dʼInvestigation Clinique, Rennes, France. [Neelapu SS] The University of Texas MD Anderson Cancer Center, Houston, Texas. [Carpio C] Vall dʼHebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain
dc.identifier.pmid32052473
dc.identifier.wos000516991200001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple